California health centers asked U.S. District Judge John A. Mendez yesterday to stop a state Medicaid drug reimbursement change due to begin tomorrow that they say would strip away all their 340B drug discount savings.
California health centers asked a federal district judge yesterday to stop a major state Medicaid drug reimbursement change due to [...] …
AbbVie will no longer offer voluntary 340B pricing on any of its orphan-designated drugs to covered entities subject to such exclusions.
AbbVie today announced conditions on 340B pricing when hospitals' contract pharmacies dispense medicines to patients. The federal government has filed [...] …
The federal government yesterday asked the federal appeals court in Washington, D.C., to review a lower court's Nov. 5 joint ruling in Novartis and United Therapeutics' 340B contract pharmacy lawsuits.
The federal government late yesterday filed notice that it is appealing a federal judge’s joint ruling in two cases last [...] …
U.S. Senate Minority Whip John Thune (R-S.D.), a strong 340B covered entity ally, is considering not running for re-election in 2022. | Gage Skidmore/Flickr
South Dakota U.S. Sen. John Thune, the second-ranking Senate Republican and a long-time 340B covered entity ally, might not run [...] …
Congress should let the VA negotiate drug prices on behalf of Medicare, U.S. Sen. Joe Manchin (W.Va.) reportedly told the Senate Democratic Caucus this week.
U.S. Sen. Joe Manchin (D-W.Va.) has suggested that the U.S. Department of Veterans Affairs (VA) be empowered to negotiate drug [...] …
SPONSORED CONTENT Confucius once said that “roads were made for journeys, not destinations.” Hudson Headwaters has been at the forefront [...] …
Citing concerns about COVID-19's Omicron variant, the 340B Coalition is considering turning its Jan. 31–Feb. 2 in-person winter conference into a hybrid in-person/virtual event.
The 340B Coalition said yesterday it is “actively exploring the potential for a hybrid [winter 2022] conference that would allow [...] …
The federal district court for western New York is hearing two 340B health centers' antitrust lawsuit against insulin and diabetes drug makers.
New York State and Virginia health centers asked a federal district judge on Monday to deny four insulin and diabetes [...] …
The U.S. Third Circuit Court of Appeals will hear Novo Nordisk and Sanofi's 340B contract pharmacy lawsuits in tandem, just as a lower court did.
A federal appeals court in Philadelphia has given drug manufacturers Novo Nordisk and Sanofi a Jan. 26 deadline to file [...] …
Boehringer Ingelheim extended its restrictions on 340B drug sales to hospitals to Ofev, its expensive specialty drug for idiopathic pulmonary fibrosis.
Drug manufacturer Boehringer Ingelheim (BI) this month extended its restrictions on 340B drug sales to hospitals to Ofev, its expensive [...] …
*Sign up for news summaries and alerts from 340B Report
Copyright © 2025 340B Report, LLC
Reproduction of material from any 340B Report page without written permission is strictly prohibited.
